Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Antibody responses to known and unknown SARS-CoV-2 infections after mRNA vaccine booster

Alexis R. Demonbreun, Amelia Sancilio, Lauren A. Vaught, Nina L. Reiser, Lorenzo Pesce, Eoin P. Sode, Brian Mustanski, Richard D’Aquila, Elizabeth M. McNally, Thomas W. McDade
doi: https://doi.org/10.1101/2022.05.06.22274719
Alexis R. Demonbreun
1Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
2Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: alexis.demonbreun@northwestern.edu t-mcdade@northwestern.edu
Amelia Sancilio
3Department of Anthropology and Institute for Policy Research, Northwestern University, Evanston, IL 60208, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauren A. Vaught
1Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
4Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nina L. Reiser
1Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
4Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorenzo Pesce
1Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
2Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eoin P. Sode
1Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
4Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian Mustanski
5Institute for Sexual and Gender Minority Health and Wellbeing and Department of Medical Social Sciences, Northwestern University, Chicago, IL 60611, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard D’Aquila
6Division of Infectious Diseases, Dept. of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth M. McNally
1Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
4Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas W. McDade
3Department of Anthropology and Institute for Policy Research, Northwestern University, Evanston, IL 60208, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: alexis.demonbreun@northwestern.edu t-mcdade@northwestern.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

We followed a fully-vaccinated (two mRNA vaccine doses) community cohort (n=41) without prior COVID-19 diagnosis from September 2021 through March 2022 through the Omicron wave following a booster mRNA vaccination. 19.5% of participants reported a known SARS-CoV-2 infection during the Omicron wave, which was confirmed by anti-nucleocapsid IgG. An additional 36.5% also developed anti-nucleocapsid IgG after the boost, consistent with unknown, asymptomatic SARS-CoV-2 infection during this period. Infection defined by anti-nucleocapsid IgG, whether known to participant or not, increased anti-spike IgG levels, relative to those lacking anti-nucleocapsid IgG, at 120 days post-booster.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Supported by the National Science Foundation 2035114, NIH 3UL1TR001422-06S4, Northwestern University Office of Research, and a generous gift from Dr. Andrew Senyei and Noni Senyei. The funding sources had no role in the study design, data collection, analysis, interpretation, or writing of the report.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All research activities were implemented under protocols approved by the institutional review board atNorthwestern University (#STU00212457 and #STU00212472).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Written requests for data should be made by qualified researchers trained in human subject confidentiality protocols to the corresponding author(s).

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 07, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Antibody responses to known and unknown SARS-CoV-2 infections after mRNA vaccine booster
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Antibody responses to known and unknown SARS-CoV-2 infections after mRNA vaccine booster
Alexis R. Demonbreun, Amelia Sancilio, Lauren A. Vaught, Nina L. Reiser, Lorenzo Pesce, Eoin P. Sode, Brian Mustanski, Richard D’Aquila, Elizabeth M. McNally, Thomas W. McDade
medRxiv 2022.05.06.22274719; doi: https://doi.org/10.1101/2022.05.06.22274719
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Antibody responses to known and unknown SARS-CoV-2 infections after mRNA vaccine booster
Alexis R. Demonbreun, Amelia Sancilio, Lauren A. Vaught, Nina L. Reiser, Lorenzo Pesce, Eoin P. Sode, Brian Mustanski, Richard D’Aquila, Elizabeth M. McNally, Thomas W. McDade
medRxiv 2022.05.06.22274719; doi: https://doi.org/10.1101/2022.05.06.22274719

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (434)
  • Anesthesia (99)
  • Cardiovascular Medicine (949)
  • Dentistry and Oral Medicine (178)
  • Dermatology (111)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (422)
  • Epidemiology (8997)
  • Forensic Medicine (4)
  • Gastroenterology (421)
  • Genetic and Genomic Medicine (1960)
  • Geriatric Medicine (191)
  • Health Economics (403)
  • Health Informatics (1330)
  • Health Policy (661)
  • Health Systems and Quality Improvement (520)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10820)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1834)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (356)
  • Occupational and Environmental Health (470)
  • Oncology (1000)
  • Ophthalmology (299)
  • Orthopedics (111)
  • Otolaryngology (183)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (581)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1907)
  • Public and Global Health (4127)
  • Radiology and Imaging (676)
  • Rehabilitation Medicine and Physical Therapy (368)
  • Respiratory Medicine (550)
  • Rheumatology (226)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (178)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (82)